Supernus Pharmaceuticals, a biopharmaceutical business, reported last week that it had been the victim of a ransomware attack that resulted in a considerable amount of data being exfiltrated from its network.
It happened in midNovember, according to Supernus, when a ransomware gang acquired data on select systems, installed malware to limit access to files, and then threatened to disclose the exfiltrated data.